Analysis plan

Process instructions including set-up and set-up verification Handling requirements Operator competency requirements Measurement systems analysis plan... 

In order to reduce unnecessary data queries, the statistics group should be consulted early in the clinical database development process to identify variables critical for data analysis. Optimally, the statistical analysis plan would already be written by the time of database development so that the queries could be designed based on the critical variables indicated in the analysis plan. However, at the database development stage, usually only the clinical protocol exists to guide the statistics and clinical data management departments in developing the query or data management plan. 

The purpose of a sampling and analysis plan (SAP) is to ensure that sampling data collection activities will be comparable to and compatible with previous data collection activities performed at the site, while providing a mechanism for planning and approving field activities. The plan also serves as a basis for estimating costs of field efforts for inclusion in the work plan. 

Suggested Format for the Sampling and Analysis Plan (Comprising the Field Sampling Plan and Quality Assurance Project Plan)... 

QA, quality assurance RI, remedial investigation FS, feasibility study SAP, sampling and analysis plan FSP, field sampling plan QAPP, quality assurance project plan OSHA, Occupational Safety and Health Administration. 

Is one specific treatment comparison important . .. any aspects of multiplicity. .. should be identified in the protocol adjustment should always be considered.. .. an explanation of why adjustment is not thought necessary should be set out in the analysis plan. (ICH E9, Section 5.6)... 

Closure Alternatives, 14 Risk Assessment, 14 Acquisition Strategy, 14 Background, 14 Closure Acquisition, 14 Closure Materiel Procurement, 15 Chemical Demilitarization Procurement Process, 16 Categories of Contamination, 16 Permitting Considerations, 16 Preparation of Detailed Engineering Requirements, 18 Sampling and Analysis Plans, 18... 

A Reports by the Committee on Review and Evalnation of the Army Chemical Stockpile Disposal Program (Stockpile Committee), 45 B Biographical Sketches of Committee Members, 47 C Closnre Planning and Implementation, 51 D J AC ADS Sampling and Analysis Plan Maps and Photographs, 53 E Examples of Information Reqnired for Two Types of Einal Closnre Snrvey Reports, 61... 

Finding 13. The samphng and analysis plan for closure, and the need to increase the number of D AAMS tubes to monitor all three agents, will require a substantial increase in the numbers and kinds of chemical analyses. 

The JACADS closure activities will involve the dismantling and destruction of that portion of the facility that cannot be decontaminated to meet the 5R cleanliness standard. An area decommissioning matrix delineates the areas that will be decontaminated and dismantled, decontaminated and abandoned in place, or solely abandoned in place (U.S. Army, 2000c). The remaining systems, structures, and components (SSCs) that are left in place must meet the Resource Conservation and Recovery Act (RCRA) criteria for decontamination as well as the Army standard of 5R. Areas that were kept free of any agent or hazardous materials will be sampled to demonstrate their cleanliness in accordance with the final closure sampling and analysis plan. 

The Facility Closure Plan includes two sampling and analysis plans. The first, Sampling and Analysis Plan for HWMU Closure (Appendix 2 in the Plan), includes requirements and procedures for conducting field sampling operations and investigations of soils and structures associated with the MDB and the HWMUs, as well as data quality objectives and field sampling protocols that could be used to verify decontamination (U.S. Army, 2000a). 

Identify technology needs Sampling and analysis plan and operations for end use ... 

JACADS Sampling and Analysis Plan Maps and Photographs... 

The US Environmental Protection Agency (USEPA 1998) describes problem formulation as an iterative process with 4 main components integration of available information, definition of assessment endpoints, definition of conceptual model, and development of an analysis plan. These 4 components apply also to probabilistic assessments. In addition, it is useful to emphasize the importance of a 5th component dehnition of the assessment scenarios. The relationships between all 5 components are depicted in Figure 2.1. Note that the bidirectional arrows represent the interdependency of the different components and imply that they may need to be revised iteratively as the formulation of the problem is rehned. 

Some sources of uncertainty and variability may have so little influence on risk that they can be held constant and not treated probabilistically in the assessment. The analysis plan should state the rationale for deciding which variables and hypotheses this applies to (USEPA 1998). 

Probabilistic models will normally not be the sole basis for decision making but will be considered together with other lines of evidence (see Figure 2.2). The way in which this will be done should be considered at the outset as part of problem formulation and specified in the analysis plan. 

The analysis plan should specify not only how the analysis will be conducted, but also how the results will be presented. Indeed, the way results will be communicated will usually influence the choice of both model structure and analysis method and is ultimately driven by the information needs of risk managers and other stakeholders and their management goals (see Figure 2.2). Careful advance planning for the communication of results is especially important for probabilistic assessments because they are more complex than deterministic assessments and less familiar to most audiences. It may be beneficial to present probabilistic and deterministic assessments together, to facilitate familiarization with the newer approaches. 

A carefully planned problem formulation needs to be developed and implemented. The analysis plan of the problem formulation will outline the uncertainty analysis methods to be used. 

In summary, due to their focus on efficacy and their use of clinical protocols, economic assessments of pharmaceutical products based upon phase III clinical trials are not without their problems. However, these issues can be developed in pharmacoeco-nomic analysis plans or through supplemental data collection activities conducted concurrently with the clinical trial. 

---